TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Urologspecialisten Skåne AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
561
|
558
|
593 |
Financial expenses |
27
|
0
![]() |
0 |
Earnings before taxes |
517
|
341
|
380 |
EBITDA |
555
|
357
|
397 |
Total assets |
1,975
|
1,727
|
1,623 |
Current assets |
1,630
|
309
|
235 |
Current liabilities |
65
|
49
|
67 |
Equity capital |
1,829
|
1,440
|
1,331 |
- share capital |
5
|
4
|
5 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
92.6%
|
83.4%
|
82.0% |
Turnover per employee |
280
|
279
|
296 |
Profit as a percentage of turnover |
92.2%
|
61.1%
|
64.1% |
Return on assets (ROA) |
27.5%
|
19.7%
|
23.4% |
Current ratio |
2507.7%
|
630.6%
|
350.7% |
Return on equity (ROE) |
28.3%
|
23.7%
|
28.5% |
Change turnover |
1
|
13
|
39 |
Change turnover % |
0%
|
2%
|
7% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.